For research use only. Not for therapeutic Use.
Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain[1].
| Catalog Number | I041387 |
| Purity | ≥95% |
| Reference | [1]. Nadecnemab. Drugbank. |
